Journal of Clinical Oncology

Rethinking Treatment Priorities in Estrogen Receptor–Low Breast Cancer

J Jincong Q. Freeman (Cancer Prevention and Control Research Program, UChicago Medicine Comprehensive Cancer Center, Chicago, IL) R Rita Nanda F Frederick M. Howard (Jincong Q. Freeman, MPH, MS, Department of Public Health Sciences, The University of Chicago, Chicago, IL, Cancer Prevention and Control Research Program, UChicago Medicine Comprehensive Cancer Center, Chicago, IL; and Rita Nanda, MD and Frederick M. Howard, MD, Section of Hematology & Oncology, Department of Medicine, The University of Chicago, Chicago, IL)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 30
Published October 20, 2025
Pages 3322-3323
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (3)

J

Jincong Q. Freeman

Cancer Prevention and Control Research Program, UChicago Medicine Comprehensive Cancer Center, Chicago, IL

R

Rita Nanda

F

Frederick M. Howard

Jincong Q. Freeman, MPH, MS, Department of Public Health Sciences, The University of Chicago, Chicago, IL, Cancer Prevention and Control Research Program, UChicago Medicine Comprehensive Cancer Center, Chicago, IL; and Rita Nanda, MD and Frederick M. Howard, MD, Section of Hematology & Oncology, Department of Medicine, The University of Chicago, Chicago, IL

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001